CLSD logo

Clearside Biomedical (CLSD) Cash From Operations

Annual CFO

-$18.14 M
-$4.77 M-35.69%

December 31, 2023


Summary


Performance

CLSD Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLSDcash flowmetrics:

Quarterly CFO

-$5.91 M
-$233.00 K-4.10%

September 30, 2024


Summary


Performance

CLSD Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLSDcash flowmetrics:

TTM CFO

-$18.95 M
+$162.00 K+0.85%

September 30, 2024


Summary


Performance

CLSD TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLSDcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CLSD Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.7%+2.7%+21.8%
3 y3 years-38.2%+2.7%+21.8%
5 y5 years+77.1%+2.7%+21.8%

CLSD Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-69.0%at low-217.0%+24.7%-9388.7%+22.5%
5 y5-year-69.0%+33.0%-217.0%+24.7%-9388.7%+30.0%
alltimeall time-165.2%+77.1%-217.0%+75.6%-9388.7%+76.1%

Clearside Biomedical Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.91 M(+4.1%)
-$18.95 M(-0.8%)
Jun 2024
-
-$5.68 M(-27.7%)
-$19.11 M(+1.8%)
Mar 2024
-
-$7.85 M(-1686.1%)
-$18.77 M(+3.5%)
Dec 2023
-$18.14 M(+35.7%)
$495.00 K(-108.1%)
-$18.14 M(-25.2%)
Sep 2023
-
-$6.08 M(+13.8%)
-$24.24 M(-0.5%)
Jun 2023
-
-$5.34 M(-26.0%)
-$24.35 M(-0.4%)
Mar 2023
-
-$7.22 M(+28.7%)
-$24.45 M(+83.0%)
Dec 2022
-$13.37 M(+24.5%)
-$5.61 M(-9.4%)
-$13.37 M(+394.3%)
Sep 2022
-
-$6.19 M(+13.7%)
-$2.70 M(-1425.5%)
Jun 2022
-
-$5.44 M(-240.6%)
$204.00 K(-115.7%)
Mar 2022
-
$3.87 M(-23.4%)
-$1.30 M(-87.9%)
Dec 2021
-$10.73 M(-18.2%)
$5.05 M(-254.2%)
-$10.73 M(-46.9%)
Sep 2021
-
-$3.28 M(-52.8%)
-$20.22 M(+3.1%)
Jun 2021
-
-$6.95 M(+25.0%)
-$19.61 M(+23.5%)
Mar 2021
-
-$5.56 M(+25.3%)
-$15.88 M(+21.0%)
Dec 2020
-$13.12 M(-51.5%)
-$4.44 M(+66.7%)
-$13.12 M(+87.6%)
Sep 2020
-
-$2.66 M(-17.4%)
-$7.00 M(-32.6%)
Jun 2020
-
-$3.22 M(+14.9%)
-$10.38 M(-39.7%)
Mar 2020
-
-$2.80 M(-266.0%)
-$17.22 M(-36.4%)
Dec 2019
-$27.07 M
$1.69 M(-127.9%)
-$27.07 M(-48.9%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$6.05 M(-39.9%)
-$53.02 M(-20.5%)
Jun 2019
-
-$10.06 M(-20.5%)
-$66.69 M(-12.5%)
Mar 2019
-
-$12.65 M(-47.8%)
-$76.20 M(-3.8%)
Dec 2018
-$79.20 M(+55.0%)
-$24.26 M(+23.0%)
-$79.20 M(+13.1%)
Sep 2018
-
-$19.72 M(+0.8%)
-$70.03 M(+9.8%)
Jun 2018
-
-$19.57 M(+25.0%)
-$63.78 M(+14.4%)
Mar 2018
-
-$15.65 M(+3.7%)
-$55.76 M(+9.2%)
Dec 2017
-$51.08 M(+124.9%)
-$15.09 M(+12.1%)
-$51.08 M(+20.3%)
Sep 2017
-
-$13.46 M(+16.5%)
-$42.45 M(+20.0%)
Jun 2017
-
-$11.55 M(+5.2%)
-$35.36 M(+20.7%)
Mar 2017
-
-$10.98 M(+70.0%)
-$29.29 M(+29.0%)
Dec 2016
-$22.71 M(+63.4%)
-$6.46 M(+1.3%)
-$22.71 M(+13.1%)
Sep 2016
-
-$6.37 M(+16.3%)
-$20.08 M(+19.1%)
Jun 2016
-
-$5.48 M(+24.7%)
-$16.86 M(+15.9%)
Mar 2016
-
-$4.40 M(+14.8%)
-$14.55 M(+4.7%)
Dec 2015
-$13.90 M(+52.4%)
-$3.83 M(+21.5%)
-$13.90 M(+38.0%)
Sep 2015
-
-$3.15 M(-0.7%)
-$10.07 M(+45.5%)
Jun 2015
-
-$3.17 M(-15.3%)
-$6.92 M(+84.7%)
Mar 2015
-
-$3.75 M
-$3.75 M
Dec 2014
-$9.12 M(+33.4%)
-
-
Dec 2013
-$6.84 M
-
-

FAQ

  • What is Clearside Biomedical annual cash flow from operations?
  • What is the all time high annual CFO for Clearside Biomedical?
  • What is Clearside Biomedical annual CFO year-on-year change?
  • What is Clearside Biomedical quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Clearside Biomedical?
  • What is Clearside Biomedical quarterly CFO year-on-year change?
  • What is Clearside Biomedical TTM cash flow from operations?
  • What is the all time high TTM CFO for Clearside Biomedical?
  • What is Clearside Biomedical TTM CFO year-on-year change?

What is Clearside Biomedical annual cash flow from operations?

The current annual CFO of CLSD is -$18.14 M

What is the all time high annual CFO for Clearside Biomedical?

Clearside Biomedical all-time high annual cash flow from operations is -$6.84 M

What is Clearside Biomedical annual CFO year-on-year change?

Over the past year, CLSD annual cash flow from operations has changed by -$4.77 M (-35.69%)

What is Clearside Biomedical quarterly cash flow from operations?

The current quarterly CFO of CLSD is -$5.91 M

What is the all time high quarterly CFO for Clearside Biomedical?

Clearside Biomedical all-time high quarterly cash flow from operations is $5.05 M

What is Clearside Biomedical quarterly CFO year-on-year change?

Over the past year, CLSD quarterly cash flow from operations has changed by +$162.00 K (+2.67%)

What is Clearside Biomedical TTM cash flow from operations?

The current TTM CFO of CLSD is -$18.95 M

What is the all time high TTM CFO for Clearside Biomedical?

Clearside Biomedical all-time high TTM cash flow from operations is $204.00 K

What is Clearside Biomedical TTM CFO year-on-year change?

Over the past year, CLSD TTM cash flow from operations has changed by +$5.29 M (+21.82%)